Industry Outlook

The dental bone graft substitute and other biomaterials market is set to reach US$ 1,786.0 Mn by 2026 from US$ 740.3 Mn in 2017 highlighting impressive growth at a compounded annual growth rate (CAGR) of 10.3% during the forecast period from 2018 to 2026. As per the statistics provided by the Global Burden of Disease Study (GBD) periodontitis is considered as the sixth most prevalent disease worldwide affecting approximately 743 million people worldwide. The global prevalence rate of periodontitis is 11.2%, factors responsible for the disease etiology are chewing of tobacco & betel nuts, craving for sugar candies and poor oral hygiene.

Bone grafts are commonly used in dental implants to restore edentulous area of missing teeth. They are frequently used to repair fractured jawbone and promote dental bone healing. Since 2015, USFDA has restricted the use of dental bone grafts and other biomaterials in patients below 18 years of age. Changing regulatory norms are a setback to the dental bone graft substitutes market.

"Excellent osteoconduction and osteoinduction properties makes allograft the most desired dental bone graft"

Allograft are usually taken from cadavers that have donated their bones and it is sourced from a bone bank. Due to their excellent osteoconduction and osteoinduction properties they are frequently used in reconstructive dental procedures as structural and particulate graft. The sterilization of allografts is a very critical procedures as incidence have been reported for a possible risk of disease transmission or reaction. Xenografts are obtained from non-human species such as bovine and corals sources which finds prominence in dental surgeries as calcified matrix. Ceramic material will be a trendsetter throughout the forecast period on account of its enhanced osteointegrative properties. It can be used alone or in combination with calcium phosphate and bioactive glass to give structural base for dental implants to the jawbones deformed due to severe atrophy.

"Increasing number of dental surgeries performed will propel the dental bone graft substitutes and other biomaterials market growth in North America"

North America is currently leading the regional segment. The key factors responsible for the dominance of North America are increasing number of dental surgeries performed and rising geriatric population with jawbone deformities. Healthcare insurers have started providing favorable reimbursement to its customer opting dental bone graft surgical procedures. In Europe the dental bone grafts market is driven by domicile of major players such as DENTSPLY International, Inc., Institut Straumann AG, Geistlich Pharma AG etc. Supportive regulatory scenario provided by European Medical Agency (EMA) in expediting product approval results in positive traction for the dental bone grafts market. Asia Pacific serves as an attractive destination for the business expansion of dental bone graft substitutes and other biomaterials by establishing subsidiaries and retail outlets for key players. Increasing number of patients suffering with oral health issues such as eroded crown and jawbone atrophy due to chewing of tobacco and betel nuts. Rampant growth in medical tourism due to affordable dental surgical procedures have a positive impact on the dental bone graft substitutes and other biomaterials market in Asia Pacific.

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

Latest market turned were studied to determine the compounded annual growth rate and market estimation. The market segmentation consists of by material and regional segment.

Market assessment was thoroughly studied to understand the organic and inorganic market growth strategies applied by key players manufacturing bone graft substitutes and other biomaterials. Existing competition among key players is mapped under the competitive landscape segment. Diverse range of dental bone graft substitutes are covered in the product portfolio segment. Archrivals competing in the market are ACE Surgical Supply Company, Inc., Geistlich Pharma AG., Biohorizons IPH, Inc., Sigma Graft Biomaterials, Biomet, Inc., DENTSPLY International, Inc., DePuy Synthes Companies, Institut Straumann AG, Medtronic, Plc., and Zimmer Holdings, Inc.

Key questions answered in this report

• How is the market assessment performed employing organic and inorganic market growth strategies?
• Who are the key players dominating in the dental grafts market?
• What are the drivers, challenges and opportunities pertaining to the dental grafts market?
• How is the competitive landscape mapped to understand the existing competition among major players?
• Which is the leading and fastest growing material segment for dental bone graft substitutes and other biomaterials market?
• Which is the leading and fastest growing regional segment for dental bone graft substitutes and other biomaterials market?

TABLE 1 Global Dental Bone Graft Substitutes and Other Biomaterials Market Portraiture
TABLE 2 Global Dental Bone Graft Substitutes and Other Biomaterials Market, by Material, 2016 – 2026 (US$ Mn)
TABLE 3 Global Natural Material Market for Dental Bone Graft Substitutes and Other Biomaterials Market, 2016 – 2026 (US$ Mn)
TABLE 4 Global Natural Allograft Material Market for Dental Bone Graft Substitutes and Other Biomaterials Market, 2016 – 2026 (US$ Mn)
TABLE 5 Global Natural Xenograft Material Market for Dental Bone Graft Substitutes and Other Biomaterials Market, 2016 – 2026 (US$ Mn)
TABLE 6 Global Ceramic Material Market for Dental Bone Graft Substitutes and Other Biomaterials Market, 2016 – 2026 (US$ Mn)
TABLE 7 Global Composite Material Market for Dental Bone Graft Substitutes and Other Biomaterials Market, 2016 – 2026 (US$ Mn)
TABLE 8 Global Polymer Material Market for Dental Bone Graft Substitutes and Other Biomaterials Market, 2016 – 2026 (US$ Mn)
TABLE 9 Global Dental Bone Graft Substitutes and Other Biomaterials Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 10 North America Dental Bone Graft Substitutes and Other Biomaterials Market, by Material, 2016 – 2026 (US$ Mn)
TABLE 11 North America Dental Bone Graft Substitutes and Other Biomaterials Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 12 Europe Dental Bone Graft Substitutes and Other Biomaterials Market, by Material, 2016 – 2026 (US$ Mn)
TABLE 13 Europe Dental Bone Graft Substitutes and Other Biomaterials Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific Dental Bone Graft Substitutes and Other Biomaterials Market, by Material, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific Dental Bone Graft Substitutes and Other Biomaterials Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Dental Bone Graft Substitutes and Other Biomaterials Market, by Material, 2016 – 2026 (US$ Mn)
TABLE 17 Latin America Dental Bone Graft Substitutes and Other Biomaterials Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa Dental Bone Graft Substitutes and Other Biomaterials Market, by Material, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa Dental Bone Graft Substitutes and Other Biomaterials Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Ace Surgical Supply Company, Inc.: Company Snapshot (Business Description; Financial Information; Raw Material Portfolio; Key Developments)
TABLE 21 BioHorizons IPH, Inc.: Company Snapshot (Business Description; Financial Information; Raw Material Portfolio; Key Developments)
TABLE 22 Biomet, Inc.: Company Snapshot (Business Description; Financial Information; Raw Material Portfolio; Key Developments)
TABLE 23 DENTSPLY International, Inc.: Company Snapshot (Business Description; Financial Information; Raw Material Portfolio; Key Developments)
TABLE 24 DePuy Synthes Companies: Company Snapshot (Business Description; Financial Information; Raw Material Portfolio; Key Developments)
TABLE 25 Geistlich Pharma AG: Company Snapshot (Business Description; Financial Information; Raw Material Portfolio; Key Developments)
TABLE 26 Institut Straumann AG.: Company Snapshot (Business Description; Financial Information; Raw Material Portfolio; Key Developments)
TABLE 27 Medtronic, Plc.: Company Snapshot (Business Description; Financial Information; Raw Material Portfolio; Key Developments)
TABLE 28 Sigma Graft Biomaterials: Company Snapshot (Business Description; Financial Information; Raw Material Portfolio; Key Developments)
TABLE 29 Zimmer Holdings, Inc.: Company Snapshot (Business Description; Financial Information; Raw Material Portfolio; Key Developments)